The European Medicines Agency has given positive opinions to two new combination drugs to treat chronic hepatitis C virus (HCV) infection, both of which directly target proteins that cause the virus to replicate in humans. ---Subscribe to MedNous to access this article--- Company News Regulation & Policy
